BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 23962087)

  • 21. 14-3-3zeta is an effector of tau protein phosphorylation.
    Hashiguchi M; Sobue K; Paudel HK
    J Biol Chem; 2000 Aug; 275(33):25247-54. PubMed ID: 10840038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
    Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
    Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoskeletal abnormalities in Alzheimer's disease.
    Lovestone S; Anderton B
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological-like assembly of tau induced by a paired helical filament core expressed at the plasma membrane.
    Campos-Peña V; Tapia-Ramírez J; Sánchez-Torres C; Meraz-Rios MA
    J Alzheimers Dis; 2009; 18(4):919-33. PubMed ID: 19749435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments.
    Gómez-Ramos A; Abad X; López Fanarraga M; Bhat R; Zabala JC; Avila J
    Brain Res; 2004 May; 1007(1-2):57-64. PubMed ID: 15064135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein.
    Dinoto L; Deture MA; Purich DL
    Microsc Res Tech; 2005 Jul; 67(3-4):156-63. PubMed ID: 16104002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
    Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA
    ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.
    Alonso A; Zaidi T; Novak M; Grundke-Iqbal I; Iqbal K
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6923-8. PubMed ID: 11381127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease.
    Navarrete LP; Guzmán L; San Martín A; Astudillo-Saavedra L; Maccioni RB
    J Alzheimers Dis; 2012; 29(1):79-88. PubMed ID: 22232002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain.
    Takahashi M; Tsujioka Y; Yamada T; Tsuboi Y; Okada H; Yamamoto T; Liposits Z
    Acta Neuropathol; 1999 Jun; 97(6):635-41. PubMed ID: 10378383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.